These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20858207)

  • 1. Characterization of the non-fibrillar α-synuclein oligomers.
    Hong DP; Han S; Fink AL; Uversky VN
    Protein Pept Lett; 2011 Mar; 18(3):230-40. PubMed ID: 20858207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein.
    Hong DP; Fink AL; Uversky VN
    J Mol Biol; 2008 Oct; 383(1):214-23. PubMed ID: 18775438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characteristics and membrane interactions of tandem α-synuclein oligomers.
    Dong C; Hoffmann M; Li X; Wang M; Garen CR; Petersen NO; Woodside MT
    Sci Rep; 2018 Apr; 8(1):6755. PubMed ID: 29712958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.
    Bickle L; Hopwood JJ; Karageorgos L
    Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):261-273. PubMed ID: 28007442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.
    Alam P; Bousset L; Melki R; Otzen DE
    J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes.
    Cai Y; Lendel C; Österlund L; Kasrayan A; Lannfelt L; Ingelsson M; Nikolajeff F; Karlsson M; Bergström J
    Biochem Biophys Res Commun; 2015 Aug; 464(1):336-41. PubMed ID: 26129771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different binding modes of α-synuclein to lipid vesicles depending on its aggregation state.
    Högen T; Levin J; Schmidt F; Caruana M; Vassallo N; Kretzschmar H; Bötzel K; Kamp F; Giese A
    Biophys J; 2012 Apr; 102(7):1646-55. PubMed ID: 22500765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of alpha-synuclein aggregate morphology on solution conditions.
    Hoyer W; Antony T; Cherny D; Heim G; Jovin TM; Subramaniam V
    J Mol Biol; 2002 Sep; 322(2):383-93. PubMed ID: 12217698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Capped Peptide of the Aggregation Prone NAC 71-82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations.
    Näsström T; Ådén J; Shibata F; Andersson PO; Karlsson BCG
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evidence that an aqueous extract of Centella asiatica modulates α-synuclein aggregation dynamics.
    Berrocal R; Vasudevaraju P; Indi SS; Sambasiva Rao KR; Rao KS
    J Alzheimers Dis; 2014; 39(2):457-65. PubMed ID: 24284367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Characterization of Individual α-Synuclein Oligomers Formed at Different Stages of Protein Aggregation by Atomic Force Microscopy-Infrared Spectroscopy.
    Zhou L; Kurouski D
    Anal Chem; 2020 May; 92(10):6806-6810. PubMed ID: 32347706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic measurements give new insights into lipid membrane permeabilization by α-synuclein oligomers.
    Stöckl M; Claessens MM; Subramaniam V
    Mol Biosyst; 2012 Jan; 8(1):338-45. PubMed ID: 22009045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic study of the inhibitory activity of Geum urbanum extract against α-Synuclein fibrillation.
    Lobbens ES; Breydo L; Skamris T; Vestergaard B; Jäger AK; Jorgensen L; Uversky V; van de Weert M
    Biochim Biophys Acta; 2016 Sep; 1864(9):1160-1169. PubMed ID: 27353564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
    Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
    Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
    Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
    Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forcing nonamyloidogenic beta-synuclein to fibrillate.
    Yamin G; Munishkina LA; Karymov MA; Lyubchenko YL; Uversky VN; Fink AL
    Biochemistry; 2005 Jun; 44(25):9096-107. PubMed ID: 15966733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90 inhibits α-synuclein aggregation by interacting with soluble oligomers.
    Daturpalli S; Waudby CA; Meehan S; Jackson SE
    J Mol Biol; 2013 Nov; 425(22):4614-28. PubMed ID: 23948507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trehalose inhibits fibrillation of A53T mutant alpha-synuclein and disaggregates existing fibrils.
    Yu WB; Jiang T; Lan DM; Lu JH; Yue ZY; Wang J; Zhou P
    Arch Biochem Biophys; 2012 Jul; 523(2):144-50. PubMed ID: 22575388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of dopamine induced alpha-synuclein oligomers.
    Rekas A; Knott RB; Sokolova A; Barnham KJ; Perez KA; Masters CL; Drew SC; Cappai R; Curtain CC; Pham CL
    Eur Biophys J; 2010 Sep; 39(10):1407-19. PubMed ID: 20309679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.